↓ Skip to main content

An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

Overview of attention for article published in Frontiers in Pharmacology, March 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
Published in
Frontiers in Pharmacology, March 2021
DOI 10.3389/fphar.2021.652455
Pubmed ID
Authors

Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, Silvia Pasquini, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 20%
Other 2 13%
Researcher 2 13%
Student > Doctoral Student 1 7%
Unspecified 1 7%
Other 4 27%
Unknown 2 13%
Readers by discipline Count As %
Medicine and Dentistry 4 27%
Biochemistry, Genetics and Molecular Biology 3 20%
Neuroscience 2 13%
Unspecified 1 7%
Materials Science 1 7%
Other 0 0%
Unknown 4 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2021.
All research outputs
#3,286,752
of 23,308,124 outputs
Outputs from Frontiers in Pharmacology
#1,469
of 16,753 outputs
Outputs of similar age
#85,472
of 428,082 outputs
Outputs of similar age from Frontiers in Pharmacology
#94
of 713 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,753 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 713 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.